ICU Medical, Inc. - Common Stock (ICUI)
161.51
+0.52 (0.32%)
ICU Medical Inc. is a leading medical device company that specializes in the development and manufacturing of innovative products for intravenous therapy, infusion systems, and related applications
The company focuses on enhancing patient safety and improving clinical outcomes through its advanced technologies, including smart infusion systems and closed-loop medication delivery solutions. With a commitment to quality and reliability, ICU Medical serves a wide range of healthcare settings, helping to streamline hospital operations and enhance the overall patient experience. Their extensive portfolio also encompasses vital components used in various healthcare environments, underscoring their role as a crucial player in the medical technology sector.
Previous Close | 160.99 |
---|---|
Open | 161.16 |
Bid | 160.00 |
Ask | 259.48 |
Day's Range | 160.16 - 163.67 |
52 Week Range | 87.65 - 196.26 |
Volume | 117,317 |
Market Cap | 3.43B |
PE Ratio (TTM) | -35.34 |
EPS (TTM) | -4.6 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 208,293 |
News & Press Releases
ICU Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ICU Medical’s presentation will be on Wednesday, January 15, 2025 at 10:30 a.m. PT (1:30 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, January 15, 2025 and Thursday, January 16, 2025.
By ICU Medical, Inc. · Via GlobeNewswire · January 3, 2025
A Glimpse Into The Expert Outlook On ICU Medical Through 4 Analystsbenzinga.com
Via Benzinga · December 11, 2024
Breaking Down ICU Medical: 4 Analysts Share Their Viewsbenzinga.com
Via Benzinga · November 13, 2024
ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance
SAN CLEMENTE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2024.
By ICU Medical, Inc. · Via GlobeNewswire · November 12, 2024
Deep Dive Into ICU Medical Stock: Analyst Perspectives (4 Ratings)benzinga.com
Via Benzinga · September 12, 2024
Earnings Scheduled For February 27, 2024benzinga.com
Companies Reporting Before The Bell • Gaotu Techedu (NYSEGOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via Benzinga · February 27, 2024
ICU Medical to Participate at the UBS Global Healthcare Conference
SAN CLEMENTE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the UBS Global Healthcare Conference being held in Rancho Palos Verdes, California, November 11-14, 2024. ICU Medical’s presentation will be on Wednesday, November 13, 2024 at 4:15 p.m. PT (7:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, November 13, 2024.
By ICU Medical, Inc. · Via GlobeNewswire · November 6, 2024
ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call
SAN CLEMENTE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2024 earnings release and conference call.
By ICU Medical, Inc. · Via GlobeNewswire · October 28, 2024
ICU Medical Recalls ParaPAC Plus Ventilators Due To Loose Outlet Connector That Can Cause Injury Or Deathbenzinga.com
Smiths Medical, a subsidiary of ICU Medical, recalls ParaPAC Plus P300 and P310 ventilators; they pose risks of injury or death.
Via Benzinga · September 20, 2024
ICU Medical Recalls Certain Tracheostomy Tubes Due To Manufacturing Defectsbenzinga.com
Smiths Medical, a subsidiary of ICU Medical, recalls Bivona neonatal, pediatric, and adult tracheostomy tubes due to a defect that may lead to serious injury or death following the FDA's classification of the issue as a serious health risk.
Via Benzinga · September 19, 2024
ICU Medical to Participate in Upcoming Investor Conferences
SAN CLEMENTE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September:
By ICU Medical, Inc. · Via GlobeNewswire · August 21, 2024
Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursdaybenzinga.com
Via Benzinga · August 8, 2024
ICUI Stock Earnings: ICU Medical Beats EPS, Beats Revenue for Q2 2024investorplace.com
ICUI stock results show that ICU Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024
ICU Medical Announces Second Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance
SAN CLEMENTE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2024.
By ICU Medical, Inc. · Via GlobeNewswire · August 7, 2024
ICU Medical Announces Time of Second Quarter 2024 Earnings Conference Call
SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2024 earnings release and conference call.
By ICU Medical, Inc. · Via GlobeNewswire · July 24, 2024
Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursdaybenzinga.com
Via Benzinga · May 9, 2024
ICUI Stock Earnings: ICU Medical Beats EPS, Beats Revenue for Q1 2024investorplace.com
ICUI stock results show that ICU Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 7, 2024
ICU Medical Announces First Quarter 2024 Results
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024.
By ICU Medical, Inc. · Via GlobeNewswire · May 7, 2024
ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call
SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call.
By ICU Medical, Inc. · Via GlobeNewswire · April 23, 2024
ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum
SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024. ICU Medical’s presentation will be on Wednesday, March 20, 2024 at 11:15 a.m. PT (2:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, March 20, 2024.
By ICU Medical, Inc. · Via GlobeNewswire · March 13, 2024
ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference
SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024. ICU Medical’s presentation will be on Monday, March 4, 2024 at 4:30 a.m. PT (7:30 a.m. ET). Company management will also be participating in one-on-one meetings on Monday, March 4, 2024.
By ICU Medical, Inc. · Via GlobeNewswire · March 1, 2024
ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · February 28, 2024